← Oncology Approval Tracker

FDA DECISION ·

Axtle

pemetrexed dipotassium · Avyxa Holdings

FDA approvalNew formulationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Pemetrexed for selected initial, maintenance and previously treated non-squamous non-small cell lung cancer settings and, with cisplatin, first-line malignant pleural mesothelioma when curative surgery is unsuitable.

LAMPGEN ANALYSIS

Why it matters

This pemetrexed dipotassium presentation adds a product for established lung and mesothelioma settings.

What research teams should watch

Verify labeled salt strength and regimen, and maintain the required folate, vitamin B12 and renal function checks.

PRIMARY RECORDS

Sources